Managing type 2 diabetes often requires more than lifestyle changes alone. Many people need medications that help control blood sugar while also reducing the risk of serious complications such as heart disease and kidney problems.
Two commonly prescribed medications in this category are Jardiance (empagliflozin) and Farxiga (dapagliflozin). Both belong to a class of drugs called SGLT2 inhibitors and offer benefits beyond glucose control. However, there are important differences that may influence which medication is the better choice for a particular patient.
This guide compares Jardiance vs Farxiga in terms of effectiveness, weight loss, cardiovascular benefits, side effects, and cost.
Jardiance vs Farxiga: Key Differences at a Glance
| Feature | Jardiance | Farxiga |
| Generic Name | Empagliflozin | Dapagliflozin |
| Drug Class | SGLT2 Inhibitor | SGLT2 Inhibitor |
| Approved for Type 2 Diabetes | Yes | Yes |
Heart Failure Benefits | Approved for reducing risk of cardiovascular death and hospitalization in certain heart failure populations | Approved for heart failure treatment in eligible adults |
| Kidney Disease Benefits | Yes | Yes |
| Usual Dose | 10 mg or 25 mg daily | 5 mg or 10 mg daily |
| Weight Loss Potential | Moderate | Moderate |
| Common Side Effects | Urinary tract infections, genital infections, and increased urination | Urinary tract infections, genital infections, and increased urination |
| Available as Combination Products | Yes | Yes |
Both medications work by helping the kidneys remove excess glucose through urine. This lowers blood sugar levels and may contribute to modest weight loss and reduced blood pressure. Because they have similar mechanisms of action, many patients wonder which is better, Jardiance or Farxiga.
The answer often depends on individual health goals and medical history.
Which Works Better for Type 2 Diabetes and Blood Sugar Control?
Jardiance and Farxiga are both effective at lowering HbA1c levels in people with type 2 diabetes. Clinical studies show that each medication can reduce HbA1c by approximately 0.5% to 1.0%, although results vary depending on starting HbA1c, kidney function, and other diabetes treatments.
Both medications start working soon after treatment begins. However, noticeable improvements in blood sugar control usually become evident over several weeks. Regular monitoring is important to assess how well the medication is performing.
Research comparing the two drugs directly suggests that their glucose-lowering effects are broadly similar. Neither medication consistently outperforms the other across all patient groups.
Jardiance may be preferred in certain individuals because of strong evidence supporting cardiovascular risk reduction. On the other hand, Farxiga has extensive data supporting benefits in heart failure and chronic kidney disease, even among some patients without diabetes.
For most people with type 2 diabetes, the difference in blood sugar control between these medications is relatively small. Other factors, such as heart health, kidney function, insurance coverage, and side effect profile, often become more important when choosing between them.
Jardiance vs Farxiga for Weight Loss, Heart Health, and Kidney Benefits
Weight Loss Benefits
Many patients search for information about Jardiance vs Farxiga for weight loss because both medications can help support modest weight reduction.
As SGLT2 inhibitors remove glucose through urine, they also eliminate calories. This process may contribute to gradual weight loss over time.
Clinical studies have reported modest weight reduction, often around 2–3 kg on average, although individual results vary. with either medication. Individual results vary based on diet, exercise habits, and overall health.
Neither medication is approved specifically for weight loss. However, patients with type 2 diabetes often appreciate this additional benefit alongside improved glucose control.
Heart Health Benefits
Heart disease remains one of the leading complications of type 2 diabetes. Both Jardiance and Farxiga have demonstrated important cardiovascular benefits.
Jardiance gained significant attention after studies showed it could reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
Farxiga has also shown impressive results in reducing hospitalization for heart failure and improving outcomes in patients with heart failure, including some individuals without diabetes.
Patients with a history of cardiovascular disease may benefit from discussing these findings with their healthcare provider when choosing a medication.
Kidney Protection
Diabetes is a major cause of chronic kidney disease worldwide. Fortunately, both medications have demonstrated kidney-protective effects.
Jardiance helps slow kidney disease progression and reduce the risk of worsening kidney function in eligible patients.
Farxiga is also widely recognized for its kidney benefits and has become an important treatment option for chronic kidney disease. Clinical trials have shown that it can help reduce the risk of kidney failure and related complications.
For patients concerned about kidney health, either medication may offer significant long-term benefits when prescribed appropriately.
Side Effects, Cost, and How to Choose Between Jardiance and Farxiga
Common Side Effects
Because both medications work similarly, their side effects are also quite similar.
The most common side effects include:
- Increased urination
- Urinary tract infections
- Genital yeast infections
- Thirst
- Dehydration
- Low blood pressure in some individuals
Most side effects are mild and manageable. Maintaining good hydration and personal hygiene may help reduce the risk of some complications.
Serious Side Effects
Although uncommon, more serious side effects can occur.
Potential risks include:
- Diabetic ketoacidosis
- Severe urinary tract infections
- Dehydration-related kidney issues
- Low blood pressure
- Allergic reactions
Patients should seek medical attention if they experience symptoms such as severe nausea, vomiting, abdominal pain, confusion, or difficulty breathing.
When discussing Farxiga vs Jardiance side effects, it is important to remember that both medications have comparable safety profiles. Individual responses may vary.
Cost Considerations
The cost of Jardiance and Farxiga can vary depending on insurance coverage, location, and pharmacy pricing.
Both medications are branded prescription drugs and may be expensive without insurance. Manufacturer savings programs or patient assistance programs may help reduce out-of-pocket costs for eligible individuals.
In some situations, one medication may be preferred simply because it is covered more favorably by a patient’s insurance plan.
How to Choose Between Jardiance and Farxiga
Choosing the right medication involves evaluating several factors.
Your healthcare provider may consider:
- Current blood sugar levels
- Heart disease history
- Heart failure diagnosis
- Kidney function
- Other medications being taken
- Insurance coverage
- Personal treatment goals
For many patients, either medication can be an excellent option. The decision often comes down to which additional benefits align best with the individual’s health needs.
Conclusion
Jardiance and Farxiga are two leading SGLT2 inhibitors that provide effective blood sugar control while offering additional benefits for heart and kidney health. Their overall effectiveness is similar, making them both valuable treatment options for people with type 2 diabetes.
When comparing Jardiance vs Farxiga for type 2 diabetes, there is no universal winner—Jardiance may be preferred for some patients based on cardiovascular considerations, while Farxiga may be preferred in others based on heart failure, kidney disease, cost, or insurance coverage.
FAQ
Is Jardiance better than Farxiga for type 2 diabetes?
Both medications are highly effective for type 2 diabetes. Their blood sugar-lowering effects are similar, and the best choice depends on individual health conditions and treatment goals.
Which causes more weight loss: Jardiance or Farxiga?
Studies suggest that both medications produce similar levels of modest weight loss. Most patients lose a few kilograms over time when combined with healthy lifestyle changes.
Does Jardiance work faster than Farxiga?
Both medications begin working soon after starting treatment. There is no major evidence that one works significantly faster than the other for blood sugar control.
Is Farxiga better for heart failure or kidney disease?
Farxiga has strong evidence supporting its use in heart failure and chronic kidney disease. However, Jardiance also provides important benefits in these areas. The best choice depends on individual medical circumstances.
What are the most common side effects of Jardiance and Farxiga?
The most common side effects include increased urination, urinary tract infections, genital yeast infections, dehydration, and thirst.
Can you switch from Jardiance to Farxiga?
Yes. Some patients switch between medications based on insurance coverage, side effects, or treatment goals. Any change should be made under the guidance of a healthcare provider.
Which is more affordable: Jardiance or Farxiga?
Pricing varies depending on insurance coverage and pharmacy discounts. One medication may be more affordable than the other based on individual insurance plans.
Can Jardiance or Farxiga be taken with metformin?
Yes. Both medications are commonly prescribed alongside metformin and are often used as part of a comprehensive diabetes treatment plan.
References
- FDA – Jardiance (empagliflozin) Prescribing Information
- FDA – Farxiga (dapagliflozin) Prescribing Information
- American Diabetes Association (ADA) – Standards of Care in Diabetes
